Skip to main content


Table 3 Final set of derived proteins representing candidate biomarker of AD

From: Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation

Alpha 1-antichymotrypsin SERPINA3 serpin peptidase inhibitor clade A, AACT, ACT
Amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease amyloid protein) APP AD1 (Alzheimer disease), ABETA (amyloid beta A4 protein)
Apolipoprotein D APOD  
Apolipoprotein E apoE AD2 (Alzheimer disease 2)
B-cell leukemia/lymphoma 2 BCL2  
Beta-site APP-Cleaving Enzyme 1 BACE1  
Butyrylcholinesterase BCHE  
C-reactive protein, pentraxin-related CRP  
Choline Acetyltransferase CHAT CHOACTase
Clusterin CLU APOJ (Apolipoprotein J)
Complement component 1, q subcomponent, beta polypeptide C1QB  
Estrogen Receptor 1 (alpha) ESR1  
Glial fibrillary acidic protein GFAP  
Heat shock 70kD protein 5 (glucose-regulated protein) HSPA5  
Interleukin 1 beta IL1B  
Interleukin 6 IL6 IFNB2 (Interferon beta-2)
Matrix Metallopeptidase 9 MMP9 CLG4B (92 kDa gelatinase, 92 kDa type IV collagenase)
Nerve Growth Factor NGF NGFB
Nitric Oxide Synthase 2A NOS2 NOS2A, INOS (Inducible NOS), HEP-NOS (Hepatocyte NOS)
PRKC, apoptosis, WT1, regulator PAWR PAR4 (Prostate apoptosis response 4 protein)
Prostaglandin-Endoperoxide Synthase 2 PTGS2 PGHS2, COX2 (Cyclooxygenase 2b)
Transforming Growth Factor, Beta 1 TGFB1  
Transthyretin TTR  
Tumor Necrosis Factor (TNF superfamily, member 2) TNF TNFA, TNF-alfa
Urokinase Plasminogen Activator Receptor PLAUR uPAR